Neuromyelitis Optica Spectrum Disorder
📧 Sign up to get email alerts when something new happens for Neuromyelitis Optica Spectrum Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2024-09-20Clinical Trial Update: Efficacy and Safety of Calculus Bovis Sativus (CBS) for Idiopathic Inflammatory Demyelinating Disease (CBSinIIDD) [NA]
This clinical trial is evaluating the efficacy and safety of Calculus Bovis Sativus (CBS) for idiopathic inflammatory demyelinating diseases…
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: Inebilizumab in Acute Neuromyelitis Optica Spectrum Disorders
A clinical trial registration indicates ongoing recruitment for Inebilizumab in acute Neuromyelitis Optica Spectrum Disorder.
-
CLINICAL_TRIALS research · 2024-08-16Clinical Trial Update: A Study to Evaluate IMC-002 in Neuromyelitis Optica Spectrum Disorder (NMOSD) Patients [Phase 1, Phase 2]
This clinical trial update describes an early-phase (Phase 1/2) study evaluating IMC-002 in neuromyelitis optica spectrum disorder, with the…
-
CLINICAL_TRIALS research · 2024-08-07Clinical Trial Update: Sun Yat-Sen Cohort of CNS Idiopathic Inflammatory Demyelinating Diseases
Sun Yat-Sen Memorial Hospital is conducting a cohort study of CNS idiopathic inflammatory demyelinating diseases and is currently recruiting…
-
CLINICAL_TRIALS research · 2024-07-11Clinical Trial Update: FcRn Antagonists (Efgartigimod) for Acute NMOSD Attack [Phase 2]
Phase 2 clinical trial evaluating the FcRn antagonist efgartigimod for acute neuromyelitis optica spectrum disorder attacks is listed as not…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-06-05Clinical Trial Update: National, Multicentric Registry Study on Neuroimmunological Diseases in China
National multicentric registry in China studying neuroimmunological diseases is currently recruiting, covering conditions such as Multiple S…
-
CLINICAL_TRIALS research · 2023-06-09Clinical Trial Update: Monitoring of Azathioprine Metabolite Concentrations and Cytokine Levels in Neuromyelitis Optica Spectrum Disorder [Phase 4]
A Phase 4 trial update evaluating azathioprine metabolite concentrations and cytokine levels in neuromyelitis optica spectrum disorder.
-
CLINICAL_TRIALS research · 2018-05-02Clinical Trial Update: Clinic Registry Study of Optic Neuromyelitis Spectrum Disease in China
Clinical registry study update on Neuromyelitis Optica Spectrum Disorder in China, sponsored by Beijing Tongren Hospital.
-
CLINICAL_TRIALS research · 2016-09-07Clinical Trial Update: The French Multiple Sclerosis Registry
This entry notes an update to the French Multiple Sclerosis Registry, run by Hospices Civils de Lyon, covering multiple sclerosis and neurom…
-
CLINICAL_TRIALS research · 2016-08-09Clinical Trial Update: Multimodel Magnetic Resonance Imaging (MRI)of Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorders
This clinical trial update describes multimodal MRI approaches for studying multiple sclerosis and neuromyelitis optica spectrum disorder.